Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 504230, 17 pages
http://dx.doi.org/10.1155/2013/504230
Review Article

The Proapoptotic Effect of Traditional and Novel Nonsteroidal Anti-Inflammatory Drugs in Mammalian and Yeast Cells

Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida MSD 2080, Malta

Received 14 May 2013; Accepted 8 July 2013

Academic Editor: Paula Ludovico

Copyright © 2013 Gianluca Farrugia and Rena Balzan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Baron and R. S. Sandler, “Nonsteroidal. anti-inflammatory drugs and cancer prevention,” Annual Review of Medicine, vol. 51, pp. 511–523, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Chan, N. Arber, J. Burn et al., “Aspirin in the chemoprevention of colorectal neoplasia: an overview,” Cancer Prevention Research, vol. 5, no. 2, pp. 164–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Rothwell, M. Wilson, C.-E. Elwin et al., “Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials,” The Lancet, vol. 376, no. 9754, pp. 1741–1750, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Rothwell, F. G. R. Fowkes, J. F. Belch, H. Ogawa, C. P. Warlow, and T. W. Meade, “Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials,” The Lancet, vol. 377, no. 9759, pp. 31–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Trujillo, H. S. Garewal, and R. E. Sampliner, “Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer: at what cost?” Digestive Diseases and Sciences, vol. 39, no. 10, pp. 2260–2266, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Shiff, L. Qiao, L.-L. Tsai, and B. Rigas, “Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 491–503, 1995. View at Google Scholar · View at Scopus
  7. T. A. Chan, P. J. Morin, B. Vogelstein, and K. W. Kinzler, “Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 681–686, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Rahman, D. K. Dhar, R. Masunaga, A. Yamanoi, H. Kohno, and N. Nagasue, “Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines,” Cancer Research, vol. 60, no. 8, pp. 2085–2089, 2000. View at Google Scholar · View at Scopus
  9. M. Pollard and P. H. Luckert, “Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats,” Journal of the National Cancer Institute, vol. 70, no. 6, pp. 1103–1105, 1983. View at Google Scholar · View at Scopus
  10. C. H. Chiu, M. F. McEntee, and J. Whelan, “Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+) mice,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 62, no. 5, pp. 269–275, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Andrews, D. Djakiew, S. Krygier, and P. Andrews, “Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells,” Cancer Chemotherapy and Pharmacology, vol. 50, no. 4, pp. 277–284, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-S. Zhao, S. Zhu, X.-W. Li et al., “Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis,” Breast Cancer Research and Treatment, vol. 117, no. 1, pp. 141–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Motawi, Y. Bustanji, S. El-Maraghy, M. O. Taha, and M. A. Al-Ghussein, “Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3,” Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. View at Google Scholar
  14. J. I. Johnsen, M. Lindskog, F. Ponthan et al., “Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo,” Cancer Research, vol. 64, no. 20, pp. 7210–7215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Cecere, A. Iuliano, F. Albano et al., “Diclofenac-induced apoptosis in the neuroblastoma cell line SH-SY5Y: possible involvement of the mitochondrial superoxide dismutase,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 801726, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Albano, A. Arcucci, G. Granato et al., “Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines,” Biochimie, vol. 95, pp. 934–945, 2013. View at Google Scholar
  17. J. L. Williams, S. Borgo, I. Hasan, E. Castillo, F. Traganos, and B. Rigas, “Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention,” Cancer Research, vol. 61, no. 8, pp. 3285–3289, 2001. View at Google Scholar · View at Scopus
  18. K. Kashfi, Y. Ryann, L. L. Qiao et al., “Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect,” Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 3, pp. 1273–1282, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Zhao, G. G. Mackenzie, O. T. Murray, Z. Zhang, and B. Rigas, “Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect,” Carcinogenesis, vol. 30, no. 3, pp. 512–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Huang, C. Zhu, Y. Sun et al., “Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect,” Carcinogenesis, vol. 31, no. 11, pp. 1982–1990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Huang, G. G. Mackenzie, Y. Sun et al., “Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds,” Cancer Research, vol. 71, no. 24, pp. 7617–7627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Chattopadhyay, R. Kodela, N. Nath et al., “Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect,” Biochemical Pharmacology, vol. 83, no. 6, pp. 715–722, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Kodela, M. Chattopadhyay, and K. Kashfi, “NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals,” ACS Medicinal Chemistry Letters, vol. 3, no. 3, pp. 257–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Chattopadhyay, R. Kodela, K. R. Olson, and K. Kashfi, “NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model,” Biochemical and Biophysical Research Communications, vol. 419, no. 3, pp. 523–528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. B. S. Reddy, C. V. Rao, A. Rivenson, and G. Kelloff, “Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats,” Carcinogenesis, vol. 14, no. 8, pp. 1493–1497, 1993. View at Google Scholar · View at Scopus
  27. L. Qiao, R. Hanif, E. Sphicas, S. J. Shiff, and B. Rigas, “Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells,” Biochemical Pharmacology, vol. 55, no. 1, pp. 53–64, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-G. Yu, J.-A. Huang, Y.-N. Yang et al., “The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells,” European Journal of Clinical Investigation, vol. 32, no. 11, pp. 838–846, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Gao, K. Niwa, W. Sun et al., “Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells,” Cancer Science, vol. 95, no. 11, pp. 901–907, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Carmona-Gutierrez, T. Eisenberg, S. Büttner, C. Meisinger, G. Kroemer, and F. Madeo, “Apoptosis in yeast: triggers, pathways, subroutines,” Cell Death and Differentiation, vol. 17, no. 5, pp. 763–773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Almeida, A. Silva, A. Mesquita, B. Sampaio-Marques, F. Rodrigues, and P. Ludovico, “Drug-induced apoptosis in yeast,” Biochimica et Biophysica Acta, vol. 1783, no. 7, pp. 1436–1448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Balzan, K. Sapienza, D. R. Galea, N. Vassallo, H. Frey, and W. H. Bannister, “Aspirin commits yeast cells to apoptosis depending on carbon source,” Microbiology, vol. 150, no. 1, pp. 109–115, 2004. View at Google Scholar · View at Scopus
  33. J. S. Van Leeuwen, R. Orij, M. A. H. Luttik, G. J. Smits, N. P. E. Vermeulen, and J. C. Vos, “Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction,” Microbiology, vol. 157, no. 3, pp. 685–694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Castaño, M. Dalmau, M. Barragán, G. Pueyo, R. Bartrons, and J. Gil, “Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells,” British Journal of Cancer, vol. 81, no. 2, pp. 294–299, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Turchanowa, N. Dauletbaev, V. Milovic, and J. Stein, “Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells,” European Journal of Clinical Investigation, vol. 31, no. 10, pp. 887–893, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. L. A. Stark, F. V. Din, R. M. Zwacka, and M. G. Dunlop, “Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells,” The FASEB Journal, vol. 15, no. 7, pp. 1273–1275, 2001. View at Google Scholar · View at Scopus
  37. B. Bellosillo, M. Piqué, M. Barragán et al., “Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells,” Blood, vol. 92, no. 4, pp. 1406–1414, 1998. View at Google Scholar · View at Scopus
  38. M. Piqué, M. Barragán, M. Dalmau, B. Bellosillo, G. Pons, and J. Gil, “Aspirin induces apoptosis through mitochondrial cytochrome c release,” FEBS Letters, vol. 480, no. 2-3, pp. 193–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. K. C. Zimmermann, N. J. Waterhouse, J. C. Goldstein, M. Schuler, and D. R. Green, “Aspirin induces apoptosis through release of cytochrome c from mitochondria,” Neoplasia, vol. 2, no. 6, pp. 505–513, 2000. View at Google Scholar · View at Scopus
  40. R. Im and Y. J. Jang, “Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells,” Biochemical and Biophysical Research Communications, vol. 424, pp. 65–70, 2012. View at Google Scholar
  41. J. J. Power, M. S. Dennis, M. J. Redlak, and T. A. Miller, “Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism,” Digestive Diseases and Sciences, vol. 49, no. 9, pp. 1518–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Gu, J. De Wang, H. H. X. Xia et al., “Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer,” Carcinogenesis, vol. 26, no. 3, pp. 541–546, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Redlak, J. J. Power, and T. A. Miller, “Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells,” American Journal of Physiology, vol. 289, no. 4, pp. G731–G738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. X. M. Zhou, B. C. Y. Wong, X. M. Fan et al., “Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak,” Carcinogenesis, vol. 22, no. 9, pp. 1393–1397, 2001. View at Google Scholar · View at Scopus
  45. H. Raza, A. John, and S. Benedict, “Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells,” European Journal of Pharmacology, vol. 668, no. 1-2, pp. 15–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Hossain, D. H. Kim, J. Y. Jang et al., “Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model,” International Journal of Oncology, vol. 40, no. 4, pp. 1298–1304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Dikshit, M. Chatterjee, A. Goswami, A. Mishra, and N. R. Jana, “Aspirin induces apoptosis through the inhibition of proteasome function,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 29228–29235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Huang, Q. He, M. J. Hillman, R. Rong, and M. S. Sheikh, “Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells,” Cancer Research, vol. 61, no. 18, pp. 6918–6924, 2001. View at Google Scholar · View at Scopus
  49. N. Babbar, N. A. Ignatenko, R. A. Casero Jr., and E. W. Gerner, “Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer,” Journal of Biological Chemistry, vol. 278, no. 48, pp. 47762–47775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Oida, B. Gopalan, R. Miyahara et al., “Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer,” Molecular Cancer Therapeutics, vol. 4, no. 2, pp. 291–304, 2005. View at Google Scholar · View at Scopus
  51. E. J. Greenspan, J. P. Madigan, L. A. Boardman, and D. W. Rosenberg, “Ibuprofen inhibits activation of nuclear β-catenin in human colon adenomas and induces the phosphorylation of GSK-3β,” Cancer Prevention Research, vol. 4, no. 1, pp. 161–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. U. T. Sankpal, M. Abdelrahim, S. F. Connelly et al., “Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer,” Prostate, vol. 72, pp. 1648–1658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Zhou, L. Huang, Y. Sun, and B. Rigas, “Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling,” Cancer Letters, vol. 273, no. 2, pp. 292–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. L. Williams, N. Nath, J. Chen et al., “Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: Implications for chemoprevention,” Cancer Research, vol. 63, no. 22, pp. 7613–7618, 2003. View at Google Scholar · View at Scopus
  55. J. I. Williams, P. Ji, N. Ouyang, X. Liu, and B. Rigas, “NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min mice,” Carcinogenesis, vol. 29, no. 2, pp. 390–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Sun and B. Rigas, “The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents,” Cancer Research, vol. 68, no. 20, pp. 8269–8277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Chattopadhyay, S. Goswami, D. B. Rodes et al., “NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation,” Cancer Letters, vol. 298, no. 2, pp. 204–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Gao, X. Liu, and B. Rigas, “Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 47, pp. 17207–17212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Chaudhary, T. Singh, P. Kapur et al., “Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis,” Toxicology and Applied Pharmacology, vol. 268, pp. 249–255, 2013. View at Google Scholar
  60. M. Chattopadhyay, R. Kodela, N. Nath, A. Barsegian, D. Boring, and K. Kashfi, “Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo,” Biochemical Pharmacology, vol. 83, no. 6, pp. 723–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. J. R. Vane, “Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs,” Nature: New biology, vol. 231, no. 25, pp. 232–235, 1971. View at Google Scholar · View at Scopus
  62. J. R. Vane, J. A. Mitchell, I. Appleton et al., “Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 6, pp. 2046–2050, 1994. View at Google Scholar · View at Scopus
  63. K. Uefuji, T. Ichikura, and H. Mochizuki, “Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer,” Clinical Cancer Research, vol. 6, no. 1, pp. 135–138, 2000. View at Google Scholar · View at Scopus
  64. L. Zhang, Y.-D. Wu, P. Li et al., “Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma,” World Journal of Gastroenterology, vol. 17, no. 41, pp. 4572–4580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. C. E. Eberhart, R. J. Coffey, A. Radhika, F. M. Giardiello, S. Ferrenbach, and R. N. Dubois, “Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas,” Gastroenterology, vol. 107, no. 4, pp. 1183–1188, 1994. View at Google Scholar · View at Scopus
  66. H. Sano, Y. Kawahito, R. L. Wilder et al., “Expression of cyclooxygenase-1 and -2 in human colorectal cancer,” Cancer Research, vol. 55, no. 17, pp. 3785–3789, 1995. View at Google Scholar · View at Scopus
  67. W. Kutchera, D. A. Jones, N. Matsunami et al., “Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 10, pp. 4816–4820, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Lupulescu, “Prostaglandins, their inhibitors and cancer,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 54, no. 2, pp. 83–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. G. N. Levy, “Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer,” FASEB Journal, vol. 11, no. 4, pp. 234–247, 1997. View at Google Scholar · View at Scopus
  70. S. J. Shiff and B. Rigas, “Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions,” Gastroenterology, vol. 113, no. 6, pp. 1992–1998, 1997. View at Google Scholar · View at Scopus
  71. D. Wang and R. N. Dubois, “Prostaglandins and cancer,” Gut, vol. 55, no. 1, pp. 115–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Oshima, J. E. Dinchuk, S. L. Kargman et al., “Suppression of intestinal polyposis in Apc(Δ716) knockout mice by inhibition of cyclooxygenase 2 (COX-2),” Cell, vol. 87, no. 5, pp. 803–809, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. P. C. Chulada, M. B. Thompson, J. F. Mahler et al., “Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice,” Cancer Research, vol. 60, no. 17, pp. 4705–4708, 2000. View at Google Scholar · View at Scopus
  74. B. S. Reddy, C. V. Rao, and K. Seibert, “Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis,” Cancer Research, vol. 56, no. 20, pp. 4566–4569, 1996. View at Google Scholar · View at Scopus
  75. N. Arber, C. J. Eagle, J. Spicak et al., “Celecoxib for the prevention of colorectal adenomatous polyps,” New England Journal of Medicine, vol. 355, no. 9, pp. 885–895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. J. A. Baron, R. S. Sandler, R. S. Bresalier et al., “A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas,” Gastroenterology, vol. 131, no. 6, pp. 1674–1682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Dai and W.-H. Wang, “Non-steroidal anti-inflammatory drugs in prevention gastric cancer,” World Journal of Gastroenterology, vol. 12, no. 19, pp. 2884–2889, 2006. View at Google Scholar · View at Scopus
  78. N. R. Jana, “NSAIDs and apoptosis,” Cellular and Molecular Life Sciences, vol. 65, no. 9, pp. 1295–1301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Sapienza and R. Balzan, “Aspirin and apoptosis,” in New Research on Aspirin and Health, C. L. Millwood, Ed., Nova Science Publishers, New York, NY, USA, 2007. View at Google Scholar
  80. C.-H. Chiu, M. F. McEntee, and J. Whelan, “Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis,” Cancer Research, vol. 57, no. 19, pp. 4267–4273, 1997. View at Google Scholar · View at Scopus
  81. R. Hanif, A. Pittas, Y. Feng et al., “Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway,” Biochemical Pharmacology, vol. 52, no. 2, pp. 237–245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. A. Hannun, “Functions of ceramide in coordinating cellular responses to stress,” Science, vol. 274, no. 5294, pp. 1855–1859, 1996. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Cao, A. T. Pearman, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott, “Intracellular unesterified arachidonic acid signals apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 21, pp. 11280–11285, 2000. View at Google Scholar · View at Scopus
  84. L. Scorrano, D. Penzo, V. Petronilli, F. Pagano, and P. Bernardi, “Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-α apoptotic signaling,” Journal of Biological Chemistry, vol. 276, no. 15, pp. 12035–12040, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. X. Zhang, S. G. Morham, R. Langenbach, and D. A. Young, “Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts,” Journal of Experimental Medicine, vol. 190, no. 4, pp. 451–459, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. D. J. E. Elder, D. E. Halton, A. Hague, and C. Paraskeva, “Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression,” Clinical Cancer Research, vol. 3, no. 10, pp. 1679–1683, 1997. View at Google Scholar · View at Scopus
  87. H. J. Thompson, S. Briggs, N. S. Paranka et al., “Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac,” Journal of the National Cancer Institute, vol. 87, no. 16, pp. 1259–1260, 1995. View at Google Scholar · View at Scopus
  88. G. A. Piazza, A. L. K. Rahm, M. Krutzsch et al., “Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis,” Cancer Research, vol. 55, no. 14, pp. 3110–3116, 1995. View at Google Scholar · View at Scopus
  89. D. Charalambous and P. E. O'Brien, “Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis,” Journal of Gastroenterology and Hepatology, vol. 11, no. 4, pp. 307–310, 1996. View at Google Scholar · View at Scopus
  90. G. A. Piazza, D. S. Alberts, L. J. Hixson et al., “Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels,” Cancer Research, vol. 57, no. 14, pp. 2909–2915, 1997. View at Google Scholar · View at Scopus
  91. R. Yamazaki, N. Kusunoki, T. Matsuzaki, S. Hashimoto, and S. Kawai, “Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells,” Journal of Pharmacy and Pharmacology, vol. 54, no. 12, pp. 1675–1679, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. B. B. Wolf and D. R. Green, “Suicidal tendencies: apoptotic cell death by caspase family proteinases,” Journal of Biological Chemistry, vol. 274, no. 29, pp. 20049–20052, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Sapienza, W. Bannister, and R. Balzan, “Mitochondrial involvement in aspirin-induced apoptosis in yeast,” Microbiology, vol. 154, no. 9, pp. 2740–2747, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Li, H. Zhu, C.-J. Xu, and J. Yuan, “Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis,” Cell, vol. 94, no. 4, pp. 491–501, 1998. View at Google Scholar · View at Scopus
  95. M. Kruidering and G. I. Evan, “Caspase-8 in apoptosis: the beginning of “the end”?” IUBMB Life, vol. 50, no. 2, pp. 85–90, 2000. View at Google Scholar · View at Scopus
  96. X. Roucou, S. Montessuit, B. Antonsson, and J.-C. Martinou, “Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein,” Biochemical Journal, vol. 368, no. 3, pp. 915–921, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Nath, G. Labaze, B. Rigas, and K. Kashfi, “NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression,” Biochemical and Biophysical Research Communications, vol. 326, no. 1, pp. 93–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Bank, J. Yu, and L. Zhang, “NSAIDs downregulate Bcl-XL and dissociate BAX and Bcl-X L to induce apoptosis in colon cancer cells,” Nutrition and Cancer, vol. 60, no. 1, pp. 98–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. I. Petrescu and C. Tarba, “Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat,” Biochimica et Biophysica Acta-Bioenergetics, vol. 1318, no. 3, pp. 385–394, 1997. View at Publisher · View at Google Scholar · View at Scopus
  100. S. A. Uyemura, A. C. Santos, F. E. Mingatto, M. C. Jordani, and C. Curti, “Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria,” Archives of Biochemistry and Biophysics, vol. 342, no. 2, pp. 231–235, 1997. View at Publisher · View at Google Scholar · View at Scopus
  101. K.-W. Oh, T. Qian, D. A. Brenner, and J. J. Lemasters, “Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition,” Toxicological Sciences, vol. 73, no. 1, pp. 44–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. A. E. Pegg, “Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy,” Cancer Research, vol. 48, no. 4, pp. 759–774, 1988. View at Google Scholar · View at Scopus
  103. D. Russell and S. H. Snyder, “Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 60, no. 4, pp. 1420–1427, 1968. View at Google Scholar · View at Scopus
  104. F. L. Meyskens Jr. and E. W. Gerner, “Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer,” Journal of Cellular Biochemistry, vol. 58, no. 22, pp. 126–131, 1995. View at Google Scholar · View at Scopus
  105. F. Scorcioni, A. Corti, P. Davalli, S. Astancolle, and S. Bettuzzi, “Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression,” Biochemical Journal, vol. 354, no. 1, pp. 217–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Li, J. N. Rao, B. L. Bass, and J.-Y. Wang, “NF-κB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells,” American Journal of Physiology, vol. 280, no. 5, pp. G992–G1004, 2001. View at Google Scholar · View at Scopus
  107. N. Babbar, E. W. Gerner, and R. A. Casero Jr., “Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells,” Biochemical Journal, vol. 394, no. 1, pp. 317–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. M. E. Martínez, T. G. O'Brien, K. E. Fultz et al., “Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7859–7864, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. F. L. Meyskens Jr., C. E. McLaren, D. Pelot et al., “Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial,” Cancer Prevention Research, vol. 1, no. 1, pp. 32–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. G. G. Mackenzie, N. Ouyang, G. Xie et al., “Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice,” Cancer Prevention Research, vol. 4, no. 7, pp. 1052–1060, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. G. G. MacKenzie, Y. Sun, L. Huang et al., “Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice,” Gastroenterology, vol. 139, no. 4, pp. 1320–1332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. P. A. Baeuerle and D. Baltimore, “Nf-κB: ten years after,” Cell, vol. 87, no. 1, pp. 13–20, 1996. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Karin, “The beginning of the end: IκB kinase (IKK) and NF-κB activation,” Journal of Biological Chemistry, vol. 274, no. 39, pp. 27339–27342, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. M.-J. Yin, Y. Yamamoto, and R. B. Gaynor, “The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β,” Nature, vol. 396, no. 6706, pp. 77–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Algül, G. Adler, and R. M. Schmid, “NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer,” International Journal of Gastrointestinal Cancer, vol. 31, pp. 71–78, 2002. View at Google Scholar
  116. K. M. Ahmed, N. Cao, and J. J. Li, “HER-2 and NF-κB as the targets for therapy-resistant breast cancer,” Anticancer Research, vol. 26, no. 6 B, pp. 4235–4243, 2006. View at Google Scholar · View at Scopus
  117. S. Setia and S. N. Sanyal, “Downregulation of NF-kappaB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer,” Molecular and Cellular Biochemistry, vol. 369, pp. 75–86, 2012. View at Google Scholar
  118. D. J. A. de Groot, E. G. E. de Vries, H. J. M. Groen, and S. de Jong, “Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic,” Critical Reviews in Oncology/Hematology, vol. 61, no. 1, pp. 52–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Kopp and S. Ghosh, “Inhibition of NF-κB by sodium salicylate and aspirin,” Science, vol. 265, no. 5174, pp. 956–959, 1994. View at Google Scholar · View at Scopus
  120. J. W. Pierce, M. A. Read, H. Ding, F. W. Luscinskas, and T. Collins, “Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration,” Journal of Immunology, vol. 156, no. 10, pp. 3961–3969, 1996. View at Google Scholar · View at Scopus
  121. P. Schwenger, D. Alpert, E. Y. Skolnik, and J. Vilček, “Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation,” Molecular and Cellular Biology, vol. 18, no. 1, pp. 78–84, 1998. View at Google Scholar · View at Scopus
  122. Y. Yamamoto, M.-J. Yin, K.-M. Lin, and R. B. Gaynor, “Sulindac inhibits activation of the NF-κB pathway,” Journal of Biological Chemistry, vol. 274, no. 38, pp. 27307–27314, 1999. View at Publisher · View at Google Scholar · View at Scopus
  123. J. R. Matthews, N. Wakasugi, J.-L. Virelizier, J. Yodoi, and R. T. Hay, “Thioredoxin regulates the DNA binding activity of N F-κB by reduction of a disulphide bond involving cysteine 62,” Nucleic Acids Research, vol. 20, no. 15, pp. 3821–3830, 1992. View at Google Scholar · View at Scopus
  124. F. V. N. Din, M. G. Dunlop, and L. A. Stark, “Evidence for colorectal cancer cell specificity of aspirin effects on NFκB signalling and apoptosis,” British Journal of Cancer, vol. 91, no. 2, pp. 381–388, 2004. View at Google Scholar · View at Scopus
  125. G. M. Borthwick, A. S. Johnson, M. Partington, J. Burn, R. Wilson, and H. M. Arthur, “Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism,” FASEB Journal, vol. 20, no. 12, pp. 2009–2016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. L. A. Stark, K. Reid, O. J. Sansom et al., “Aspirin activates the NF-κB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer,” Carcinogenesis, vol. 28, no. 5, pp. 968–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Cho, J. Gwak, S. Park et al., “Diclofenac attenuates Wnt/β-catenin signaling in colon cancer cells by activation of NF-κB,” FEBS Letters, vol. 579, no. 20, pp. 4213–4218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. K.-A. Sheppard, D. W. Rose, Z. K. Haque et al., “Transcriptional activation by NF-κB requires multiple coactivators,” Molecular and Cellular Biology, vol. 19, no. 9, pp. 6367–6378, 1999. View at Google Scholar · View at Scopus
  129. M. H. Cobb and E. J. Goldsmith, “How MAP kinases are regulated,” Journal of Biological Chemistry, vol. 270, no. 25, pp. 14843–14846, 1995. View at Publisher · View at Google Scholar · View at Scopus
  130. P. Schwenger, P. Bellosta, I. Vietor, C. Basilico, E. Y. Skolnik, and J. Vilček, “Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 2869–2873, 1997. View at Publisher · View at Google Scholar · View at Scopus
  131. P. Schwenger, E. Y. Skolnik, and J. Vilček, “Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate,” Journal of Biological Chemistry, vol. 271, no. 14, pp. 8089–8094, 1996. View at Publisher · View at Google Scholar · View at Scopus
  132. M. K. Jones, H. Wang, B. M. Peskar et al., “Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing,” Nature Medicine, vol. 5, no. 12, pp. 1418–1423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  133. Z. Xia, M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg, “Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis,” Science, vol. 270, no. 5240, pp. 1326–1331, 1995. View at Google Scholar · View at Scopus
  134. Z. Dong, C. Huang, R. E. Brown, and W.-Y. Ma, “Inhibition of activator protein 1 activity and neoplastic transformation by aspirin,” Journal of Biological Chemistry, vol. 272, no. 15, pp. 9962–9970, 1997. View at Publisher · View at Google Scholar · View at Scopus
  135. T. R. Hundley and B. Rigas, “Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 1, pp. 25–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Benhar, D. Engelberg, and A. Levitzki, “ROS, stress-activated kinases and stress signaling in cancer,” EMBO Reports, vol. 3, no. 5, pp. 420–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  137. R. T. Moon, B. Bowerman, M. Boutros, and N. Perrimon, “The promise and perils of Wnt signaling through β-catenin,” Science, vol. 296, no. 5573, pp. 1644–1646, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. X. P. Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow, “β-catenin expression is altered in human colonic aberrant crypt foci,” Cancer Research, vol. 61, no. 22, pp. 8085–8088, 2001. View at Google Scholar · View at Scopus
  139. J. M. Chiang, Y. H. Wu Chou, T. C. Chen, K. F. Ng, and J. L. Lin, “Nuclear β-catenin expression is closely related to ulcerative growth of colorectal carcinoma,” British Journal of Cancer, vol. 86, no. 7, pp. 1124–1129, 2002. View at Google Scholar · View at Scopus
  140. E. J. Chung, S.-G. Hwang, P. Nguyen et al., “Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin,” Blood, vol. 100, no. 3, pp. 982–990, 2002. View at Publisher · View at Google Scholar · View at Scopus
  141. D. Lu, Y. Zhao, R. Tawatao et al., “Activation of the Wnt signaling pathway in chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 3118–3123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  142. W. Lu, H. N. Tinsley, A. Keeton, Z. Qu, G. A. Piazza, and Y. Li, “Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation,” European Journal of Pharmacology, vol. 602, no. 1, pp. 8–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. P. Cowin, T. M. Rowlands, and S. J. Hatsell, “Cadherins and catenins in breast cancer,” Current Opinion in Cell Biology, vol. 17, no. 5, pp. 499–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Shtutman, J. Zhurinsky, I. Simcha et al., “The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5522–5527, 1999. View at Publisher · View at Google Scholar · View at Scopus
  145. N. Nath, K. Kashfi, J. Chen, and B. Rigas, “Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 22, pp. 12584–12589, 2003. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Dihlmann, A. Siermann, and M. Von Knebel Doeberitz, “The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling,” Oncogene, vol. 20, no. 5, pp. 645–653, 2001. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Dihlmann, S. Klein, and M. V. K. Doeberitz Mv, “Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin,” Molecular cancer therapeutics, vol. 2, no. 6, pp. 509–516, 2003. View at Google Scholar · View at Scopus
  148. C. L. Bos, L. L. Kodach, G. R. Van Den Brink et al., “Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A,” Oncogene, vol. 25, no. 49, pp. 6447–6456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Pathi, I. Jutooru, G. Chadalapaka, V. Nair, S. O. Lee, and S. Safe, “Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (sp) transcription factors,” PLoS ONE, vol. 7, Article ID e48208, 2012. View at Google Scholar
  150. P. L. Rice, J. Kelloff, H. Sullivan et al., “Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells,” Molecular cancer therapeutics, vol. 2, no. 9, pp. 885–892, 2003. View at Google Scholar · View at Scopus
  151. Y. Wang, X. Chen, W. Zhu, H. Zhang, S. Hu, and X. Cong, “Growth inhibition of mesenchymal stem cells by aspirin: involvement of the wnt/β-catenin signal pathway,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 8, pp. 696–701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. H. Li, L. Liu, M. L. David et al., “Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve β-catenin and cyclin D1 down-regulation,” Biochemical Pharmacology, vol. 64, no. 9, pp. 1325–1336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  153. L. Deng, S. Hu, A. R. Baydoun, J. Chen, X. Chen, and X. Cong, “Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/β-catenin pathway,” Cell Proliferation, vol. 42, no. 6, pp. 721–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. C. V. Rao, B. S. Reddy, V. E. Steele et al., “Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets,” Molecular Cancer Therapeutics, vol. 5, no. 6, pp. 1530–1538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. N. Nath, R. Vassell, M. Chattopadhyay, M. Kogan, and K. Kashfi, “Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/β-catenin/TCF-4 signaling,” Biochemical Pharmacology, vol. 78, no. 10, pp. 1298–1304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. C. Zhu, K. W. Cheng, N. Ouyang et al., “Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts,” Stem Cells, vol. 30, pp. 2065–2075, 2012. View at Google Scholar
  157. M. Adachi, H. Sakamoto, R. Kawamura, W. Wang, K. Imai, and Y. Shinomura, “Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells,” Histology and Histopathology, vol. 22, no. 4–6, pp. 437–442, 2007. View at Google Scholar · View at Scopus
  158. B. Rigas, “Novel agents for cancer prevention based on nitric oxide,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1364–1368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. E. Fernandes, S. A. Toste, J. L. F. C. Lima, and S. Reis, “The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species,” Free Radical Biology and Medicine, vol. 35, no. 9, pp. 1008–1017, 2003. View at Publisher · View at Google Scholar · View at Scopus
  160. D. Costa, A. Gomes, S. Reis, J. L. F. C. Lima, and E. Fernandes, “Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs,” Life Sciences, vol. 76, no. 24, pp. 2841–2848, 2005. View at Publisher · View at Google Scholar · View at Scopus
  161. A. El Midaoui, R. Wu, and J. De Champlain, “Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats,” Journal of Hypertension, vol. 20, no. 7, pp. 1407–1412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  162. T. Ishizuka, A. Niwa, M. Tabuchi, K. Ooshima, and H. Higashino, “Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats,” Life Sciences, vol. 82, no. 13-14, pp. 806–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. S. S. Kumari, A. Varghese, D. Muraleedharan, and V. P. Menon, “Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation,” Indian Journal of Experimental Biology, vol. 28, no. 5, pp. 480–485, 1990. View at Google Scholar · View at Scopus
  164. L.-Y. Qiu, J. Yu, Y. Zhou, and C.-H. Chen, “Protective effects and mechanism of action of aspirin on focal cerebral ischemia-reperfusion in rats,” Yaoxue Xuebao, vol. 38, no. 8, pp. 561–564, 2003. View at Google Scholar · View at Scopus
  165. M. Tauseef, K. K. Sharma, and M. Fahim, “Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action,” European Journal of Pharmacology, vol. 556, no. 1–3, pp. 136–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  166. S. S. Kanwar, K. Vaiphei, B. Nehru, and S. N. Sanyal, “Antioxidative effects of nonsteroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 27, no. 2, pp. 89–100, 2008. View at Google Scholar · View at Scopus
  167. E. C. Yiannakopoulou and E. Tiligada, “Protective effect of salicylates against hydrogen peroxide stress in yeast,” Journal of Applied Microbiology, vol. 106, no. 3, pp. 903–908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. H. Kusuhara, H. Komatsu, H. Sumichika, and K. Sugahara, “Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells,” European Journal of Pharmacology, vol. 383, no. 3, pp. 331–337, 1999. View at Publisher · View at Google Scholar · View at Scopus
  169. C. Giardina and M. S. Inan, “Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells,” Biochimica et Biophysica Acta, vol. 1401, no. 3, pp. 277–288, 1998. View at Publisher · View at Google Scholar · View at Scopus
  170. Y. M. Chung, Y. S. Bae, and S. Y. Lee, “Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis,” Free Radical Biology and Medicine, vol. 34, no. 4, pp. 434–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  171. T. Minami, M. Adachi, R. Kawamura, Y. Zhang, Y. Shinomura, and K. Imai, “Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity,” Clinical Cancer Research, vol. 11, no. 14, pp. 5248–5256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. E. Herrero, J. Ros, G. Bellí, and E. Cabiscol, “Redox control and oxidative stress in yeast cells,” Biochimica et Biophysica Acta, vol. 1780, no. 11, pp. 1217–1235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. V. Battaglia, M. Salvi, and A. Toninello, “Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria,” Journal of Biological Chemistry, vol. 280, no. 40, pp. 33864–33872, 2005. View at Publisher · View at Google Scholar · View at Scopus
  174. H. Raza and A. John, “Implications of altered glutathione metabolism in aspirin-induced oxidative stress and mitochondrial dysfunction in HepG2 cells,” PLoS ONE, vol. 7, no. 4, Article ID e36325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Sapienza and R. Balzan, “Metabolic aspects of aspirin-induced apoptosis in yeast,” FEMS Yeast Research, vol. 5, no. 12, pp. 1207–1213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  176. S. Fukuda and L. M. Pelus, “Survivin, a cancer target with an emerging role in normal adult tissues,” Molecular Cancer Therapeutics, vol. 5, no. 5, pp. 1087–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  177. M. Lu, A. Strohecker, F. Chen et al., “Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels,” Clinical Cancer Research, vol. 14, no. 10, pp. 3168–3176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. M. Wang, Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang, “Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2,” Journal of Biological Chemistry, vol. 277, no. 9, pp. 7341–7347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  179. S. Chada, R. B. Sutton, S. Ekmekcioglu et al., “MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 Family,” International Immunopharmacology, vol. 4, no. 5, pp. 649–667, 2004. View at Publisher · View at Google Scholar · View at Scopus
  180. Z.-Z. Su, M. T. Madireddi, J. J. Lin et al., “The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14400–14405, 1998. View at Publisher · View at Google Scholar · View at Scopus
  181. H. Jiang, Z.-Z. Su, J. J. L. Jiao Jiao Lin, N. I. Goldstein, C. S. H. Young, and P. B. Fisher, “The melanoma differentiation associated gene mda-7 suppresses cancer cell growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 17, pp. 9160–9165, 1996. View at Publisher · View at Google Scholar · View at Scopus
  182. Y. Saito, R. Miyahara, B. Gopalan et al., “Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation- associated-7 (mda-7)/interleukin-24 (IL-24) gene,” Cancer Gene Therapy, vol. 12, no. 3, pp. 238–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. T. Saeki, A. Mhashilkar, X. Swanson et al., “Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo,” Oncogene, vol. 21, no. 29, pp. 4558–4566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  184. Y. Sun, J. Chen, and B. Rigas, “Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death,” Carcinogenesis, vol. 30, no. 1, pp. 93–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  185. B. Rigas and Y. Sun, “Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer,” British Journal of Cancer, vol. 98, no. 7, pp. 1157–1160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. Y. Qin, W. Dai, Y. Wang, X. G. Gong, and M. Lu, “Fe-SOD cooperates with Nutlin3 to selectively inhibit cancer cells in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 431, pp. 169–175, 2013. View at Google Scholar
  187. E. Ueta, K. Yoneda, T. Kimura et al., “Mn-SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and γ-rays regulating expression of the BcL-2 family proteins, COX-2 and p21,” International Journal of Cancer, vol. 94, no. 4, pp. 545–550, 2001. View at Publisher · View at Google Scholar · View at Scopus